A new urine test developed at the University of Michigan Rogel Cancer Center could change how aggressive prostate cancer is detected. Called MyProstateScore 2.0 (MPS2), the test screens for genetic markers linked to high-grade disease without requiring a biopsy, MRI, or rectal exam. Read the full article to learn how the test works and what it could mean for prostate cancer screening.